EGFR overexpression is not common in patients with head and neck cancer. Cell lines are not representative for the clinical situation in this indicationSami S. Khaznadar(University of Bonn), Oliver von Ahsen(Bayer (Germany))OncotargetJune 22, 201810.18632/oncotarget.25656Cited by 20SaveCiteExport RISWatch citationsRelated PapersCirculating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition|BMC Cancer|2012|560